Pre-Test Probability
The estimated probability that a patient has a condition before a diagnostic test result is known, based on prevalence and clinical presentation.
Explore comprehensive, evidence-informed explanations of key health economics concepts, including their development, application and relationships to other concepts. Published entries are validated through human expert review.
The estimated probability that a patient has a condition before a diagnostic test result is known, based on prevalence and clinical presentation.
The difference between a value predicted by a statistical model and the value that is actually observed.
A range calculated to contain a future individual observation with a specified confidence, unlike a confidence interval describing a population parameter.
The total proportion of a population with a particular condition at a given time, covering both new and pre-existing cases.
The absolute difference in the prevalence of a condition between two groups, giving a direct measure of disparity in disease burden.
A measure comparing the prevalence of a condition between two groups, calculated as the ratio of one group's prevalence to the other's.
The proportion of disease cases avoided in a population due to a protective exposure or intervention, the counterpart to the attributable fraction.
In principal component analysis, a derived variable combining original observed variables to capture the maximum possible variance, uncorrelated with prior components.
In Bayesian statistics, the probability distribution representing existing beliefs about a parameter before observing new data.
The odds that a hypothesis is true before incorporating new evidence, the starting point for Bayesian updating alongside a likelihood ratio.
The estimated probability that an individual would receive a particular treatment given their observed characteristics, used to balance confounders in observational studies.
A statistical technique pairing treated individuals with similar untreated individuals based on an estimated propensity score, balancing measured confounding variables.
A descriptive statistic dividing a ranked dataset into four equal-sized groups, marking the twenty-fifth, fiftieth, and seventy-fifth percentiles.
In a mixed effects model, the components representing how individual units, such as patients, vary around an overall average relationship.
A meta-analysis model allowing genuine variation in the true treatment effect across studies, adding a between-study variance parameter to the estimate.
An approach combining evidence that explicitly allows for and estimates genuine variation in the true effect between studies, rather than assuming one common effect.
The process of assigning trial participants to treatment groups by chance, producing groups comparable on both known and unknown influencing factors.
A dispersion measure calculated as the difference between the maximum and minimum values in a dataset, sensitive to extreme outliers.
The absolute difference between the incidence rates in two groups, giving a direct measure of the excess rate of disease from an exposure.
A measure comparing the incidence rates of an outcome between two groups, accounting for differences in person-time at risk.